New Insights into Adipose-Derived Stem Cells (ADSCs)
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Stem Cells".
Deadline for manuscript submissions: 15 August 2024 | Viewed by 4284
Special Issue Editors
Interests: adipose stem cells; regenerative medicine; smart biomaterials; osteoarthritis; novel technologies; exosomes
Special Issues, Collections and Topics in MDPI journals
Interests: stem cells; tissue engineering; extracellular vesicles; biomaterials; cryopreservation; clinical translation
Interests: stem cells; tissue engineering; extracellular vesicles; biomaterials; immunology; ageing; extracellular matrix
Special Issue Information
Dear Colleagues,
Adipose-derived stem cells (ASCs) hold promise for a myriad of regenerative medicine applications. Isolated from ubiquitous and clinically accessible adipose tissue reservoirs, ASCs exhibit the capacity for multipotent differentiation into adipocyte, chondrocyte, and osteocyte lineages. Notably, ASCs possess distinctive immunomodulatory properties, underscoring their potential for use in treating autoimmune disorders as well as coordinating the immune response to foster tissue repair. Recent investigations have unveiled their intricate paracrine signaling mechanisms and their role in angiogenesis, implicating ASCs to be key orchestrators of regenerative processes.
This Special Issue aims to unravel the latest discoveries and advancements in the field of adipose-derived stem cells, including original research articles and comprehensive reviews that explore the molecular mechanisms governing adipogenic differentiation, immunomodulatory properties, paracrine signaling, and their clinical implications. With a focus on bridging the gap between fundamental research and clinical translation, this Special Issue also offers a platform with which to showcase emerging therapeutics utilizing ASCs, including ASC-based cell therapies, ASC-derived exosomes, and ASC-based tissue-engineered constructs, as well as efforts focused on streamlining the manufacturing and implementation of these therapeutics.
Dr. Francesco De Francesco
Dr. Arthi Shridhar
Dr. William D’Angelo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- adipose-derived stem cells
- immunomodulation
- exosomes
- cell therapy
- clinical translation